AFT-EPO (Asterion)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAFT-EPO (Asterion)
Drug Alias NameAFT-erythropoietin (Asterion)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAsterion Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAsterion Ltd
Active IndicationsN/A
Inactive IndicationsAnemia

Other Information

ATC CodeN/A
Related LinksN/A